NEW YORK , July 30, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sou
NEW YORK , July 30, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources of
NEW YORK , July 30, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of t
NEW YORK , July 30, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources of
Investors interested in stocks from the Financial - Investment Management sector have probably already heard of Federated Hermes (FHI) and Cohen & Steers Inc (CNS). But which of these two stocks offer
Elevated ranking reflects market demand for SmartWall ONE™ and the new CORE solution LONDON , July 24, 2025 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQX: DDOSF), the DDoS protection spe
Transforming a promising molecule into a clinically viable therapeutic platform Jupiter, Florida, July 23, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Compan
– Video webcast now available on-demand  HOUSTON, TX / ACCESS Newswire / July 22, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing i

Cohen & Steers Reports Solid Q2

11:49am, Monday, 21'st Jul 2025
Cohen & Steers (CNS 1.95%), a global investment manager known for its focus on real assets and alternative income, released its second quarter fiscal 2025 earnings on July 17, 2025. Management comment
Comprehensive review of broad pipeline targeting Alzheimer's disease agitation, depression, narcolepsy, fibromyalgia, ADHD, and smoking cessation, with new data analyses
Cohen & Steers, Inc. (NYSE:CNS ) Q2 2025 Earnings Conference Call July 18, 2025 10:00 AM ET Company Participants Brian William Heller - Senior VP & Corporate Counsel Jon Young Cheigh - President & Chi
HOUSTON, TX / ACCESS Newswire / July 18, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for pr
NEW YORK , July 17, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported its results for the quarter ended June 30, 2025. The earnings release along with the accompanying earnings pres
Investors looking for stocks in the Financial - Investment Management sector might want to consider either AllianceBernstein (AB) or Cohen & Steers Inc (CNS). But which of these two stocks presents in
The Joint Society for Neuro-Oncology (SNO) and the American Society of Clinical Oncology (ASCO) focus on the rapidly evolving area of central nervous system metastases
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE